Request that the FDA implement urgent and decisive measures to protect animal and public health in light of mounting evidence regarding the risks associated with Zorbium (buprenorphine, NADA 141547, Schedule III opioid)
🏛 Food and Drug Administration (FDA)FDA-2025-P-2977
Documents
1
Total comments
6
all analyzed
Comment status
Open
Last activity
Jun 29, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Other· Aug 11, 2025No comment period💬 6